Serum ischemia-modified albumin levels in an experimental acute mesenteric ischemia model

Acad Emerg Med. 2010 Nov;17(11):1233-8. doi: 10.1111/j.1553-2712.2010.00916.x.

Abstract

Objectives: This experimental study aimed to assess the changes in the levels of serum ischemia-modified albumin (IMA) and interleukin-6 (IL-6) by time in cases of acute mesenteric ischemia due to superior mesenteric artery occlusion.

Methods: Twenty-one New Zealand rabbits were randomly divided into three groups. Blood samples were collected at hours 0, 1, 3, and 6 from animals in a control group; a sham group following a simple laparotomy; and in an ischemia group following superior mesenteric artery ligation. All blood samples were analyzed for serum IMA and IL-6 levels, and then the time-dependent changes of biomarkers were investigated.

Results: The serum IMA levels of the ischemia group at hours 3 and 6 were significantly higher than those of the control and sham groups (hour 3, p = 0.017; hour 6, p = 0.001). The increase in serum IL-6 levels in the ischemia group at hours 1, 3, and 6 compared to the control and sham groups was also significant (hour 1, p = 0.002; hour 3, p = 0.003; hour 6, p = 0.003).

Conclusions: IMA may be helpful as a marker in the diagnosis of acute mesenteric ischemia; however, its diagnostic value and use as a routine biochemical test should be assessed in further studies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biomarkers / blood
  • Female
  • Interleukin-6 / blood*
  • Intestines / blood supply
  • Ischemia / blood*
  • Mesenteric Arteries / pathology
  • Mesenteric Vascular Occlusion
  • Mucous Membrane / pathology
  • Rabbits
  • Random Allocation
  • Serum Albumin / analysis*

Substances

  • Biomarkers
  • Interleukin-6
  • Serum Albumin